Stay updated on Elunate® Phase IV Study in Chinese Patients Clinical Trial
Sign up to get notified when there's something new on the Elunate® Phase IV Study in Chinese Patients Clinical Trial page.

Latest updates to the Elunate® Phase IV Study in Chinese Patients Clinical Trial page
- Check3 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check10 days agoChange DetectedA site-wide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The study record remains inaccessible behind a 403 error.SummaryDifference1%

- Check17 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check24 days agoChange DetectedThe revision label in the ClinicalTrials.gov page footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check31 days agoChange DetectedThe study record for the Phase IV Elunate® (fruquintinib) study has been replaced by a 403 Forbidden error page.SummaryDifference15%

- Check45 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the study details. This blocks access to the record and navigation, reflecting a site access issue rather than a data update.SummaryDifference15%

Stay in the know with updates to Elunate® Phase IV Study in Chinese Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elunate® Phase IV Study in Chinese Patients Clinical Trial page.